Note: Compounded medications are prepared based on specific patient needs and are not reviewed or approved by the FDA for safety or effectiveness
Sustained Weight Maintenance: The SCALE Maintenance trial demonstrated that 81.4% of Liraglutide-treated patients maintained their initial 5% weight loss, compared to only 48.9% of placebo-treated patients , proving its effectiveness for long-term weight management rather than just initial loss
To learn more first, Schedule a consultation with our team
Show you exactly how to prepare and administer the medication Teach correct injection techniques and rotation sites Discuss what sensations are normal and which symptoms require a call We believe education reduces anxiety
Both treatments are clinically proven to support weight loss when combined with lifestyle changes
Evidence: GLP-1 Medications and Cholesterol Semaglutide and Tirzepatide Earlier GLP-1s like semaglutide and dual agonists like tirzepatide already showed modest improvements in lipid profiles: LDL cholesterol reduction by 510% Triglyceride reduction by 1520% Mild HDL increase These effects were partly due to weight loss , but researchers suspected other mechanisms were at play